AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7263
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:77
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virology and metabolic therapy areas. The company also offers medicines for neurological disorders and other serious health conditions. AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies. The company its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
AbbVie Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Stem CentRx Raises more than USD100 Million in Financing Round 11
Partnerships 12
AbbVie Enters into Licensing Agreement with Cerveau Technologies 12
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 13
Enterome Enters into Co-Development Agreement with AbbVie 14
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 15
Debt Offering 16
AbbVie Raises USD1.75 Billion in Public Offering of 4.875% Notes Due 2048 16
AbbVie Raises USD1.25 Billion in Public Offering of 3.375% Notes Due 2021 18
AbbVie Raises USD1.75 Billion in Public Offering of 4.25% Notes Due 2028 20
AbbVie Raises USD1.25 Billion in Public Offering of 3.75% Notes Due 2023 22
AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 24
AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 25
AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 26
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 27
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 29
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 31
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 33
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 35
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 37
AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 39
AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 40
AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 41
AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 42
AbbVie Inc – Key Competitors 43
AbbVie Inc – Key Employees 44
AbbVie Inc – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 54
Strategy And Business Planning 54
Jan 09, 2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance 54
Financial Announcements 55
Jul 27, 2018: AbbVie Reports Second-Quarter 2018 Financial Results 55
Apr 26, 2018: AbbVie Reports First-Quarter 2018 Financial Results 58
Jan 26, 2018: AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results 60
Oct 27, 2017: AbbVie Reports Third-Quarter 2017 Financial Results 62
Jul 28, 2017: AbbVie Reports Second-Quarter 2017 Financial Results 64
Apr 27, 2017: AbbVie Reports First-Quarter 2017 Financial Results 66
Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 68
Corporate Communications 70
Aug 20, 2018: AbbVie announces 100 million donation to Ronald McDonald House Charities to support hospitalized children and their families 70
May 22, 2018: AbbVie Donates $100 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico 71
Sep 07, 2017: AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year 73
Legal and Regulatory 74
Jul 31, 2017: AbbVie Announces Delisting from Euronext Paris 74
Product News 75
May 17, 2017: AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology Annual Meeting 75
Appendix 77
Methodology 77
About GlobalData 77
Contact Us 77
Disclaimer 77

List of Tables
AbbVie Inc, Medical Equipment, Key Facts, 2017 2
AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AbbVie Inc, Deals By Market, 2012 to YTD 2018 9
AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Stem CentRx Raises more than USD100 Million in Financing Round 11
AbbVie Enters into Licensing Agreement with Cerveau Technologies 12
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 13
Enterome Enters into Co-Development Agreement with AbbVie 14
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 15
AbbVie Raises USD1.75 Billion in Public Offering of 4.875% Notes Due 2048 16
AbbVie Raises USD1.25 Billion in Public Offering of 3.375% Notes Due 2021 18
AbbVie Raises USD1.75 Billion in Public Offering of 4.25% Notes Due 2028 20
AbbVie Raises USD1.25 Billion in Public Offering of 3.75% Notes Due 2023 22
AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 24
AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 25
AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 26
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 27
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 29
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 31
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 33
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 35
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 37
AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 39
AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 40
AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 41
AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 42
AbbVie Inc, Key Competitors 43
AbbVie Inc, Key Employees 44
AbbVie Inc, Subsidiaries 45

List of Figures
AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AbbVie Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Versantis AG-製薬・医療分野:企業M&A・提携分析
    Summary Versantis AG (Versantis), is a preclinical stage pharmaceutical company which offers new medicines and diagnostics for treating liver diseases. It’s lead pipeline product VS-01, capable of removing toxic agents from the organism and save patients from prescription and illicit drug overdoses. …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • BioPorto AS (BIOPOR):企業の財務・戦略的SWOT分析
    BioPorto AS (BIOPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • Orthofix International N.V. (OFIX):医療機器:M&Aディール及び事業提携情報
    Summary Orthofix International NV (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation produc …
  • Southern California Gas Co:企業の戦略的SWOT分析
    Southern California Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Omaxe Ltd:企業の戦略・SWOT・財務情報
    Omaxe Ltd - Strategy, SWOT and Corporate Finance Report Summary Omaxe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務分析
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BHP:企業の戦略・SWOT・財務情報
    BHP - Strategy, SWOT and Corporate Finance Report Summary BHP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Banque Profil de Gestion SA:企業の戦略・SWOT・財務情報
    Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report Summary Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Indiabulls Real Estate Ltd:企業の戦略・SWOT・財務情報
    Indiabulls Real Estate Ltd - Strategy, SWOT and Corporate Finance Report Summary Indiabulls Real Estate Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bilcare Ltd (526853):企業の財務・戦略的SWOT分析
    Bilcare Ltd (526853) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hellenic Telecommunications Organization S.A. (HTO):企業の財務・戦略的SWOT分析
    Hellenic Telecommunications Organization S.A. (HTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s ke …
  • Immunodiagnostic Systems Holdings plc (IDH):製品パイプライン分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Biomm SA (BIOM3):製薬・医療:M&Aディール及び事業提携情報
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Omron Corp (6645):企業の財務・戦略的SWOT分析
    Omron Corp (6645) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆